Next Biomedical Co.,Ltd. (KOSDAQ:389650)

South Korea flag South Korea · Delayed Price · Currency is KRW
88,500
-9,500 (-9.69%)
At close: Dec 5, 2025
113.00%
Market Cap 726.04B
Revenue (ttm) 14.90B
Net Income (ttm) -117.78M
Shares Out 8.20M
EPS (ttm) -603.13
PE Ratio n/a
Forward PE 253.64
Dividend n/a
Ex-Dividend Date n/a
Volume 345,824
Average Volume 200,239
Open 96,400
Previous Close 98,000
Day's Range 88,200 - 96,500
52-Week Range 35,500 - 101,000
Beta n/a
RSI 65.93
Earnings Date Mar 13, 2026

About Next Biomedical

Next Biomedical Co.,Ltd. engages in the research and development, production, and development of therapeutics, drug delivery system and drug-medical device products in South Korea. It offers hemostatic material for endoscope; and microspheres for vascular embolization. The company was founded in 2014 and is based in Incheon, South Korea. [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 2014
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 389650
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.